Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Interstitial lung disease (connective tissue disease)

  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
    Riccardo Messina, Alida Benfante, Daniela Castiglia, Claudia I. Gruttad'Auria, Nicola Scichilone
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4888; DOI: 10.1183/13993003.congress-2016.PA4888
  • Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
    Douglas Mapel, Melissa Roberts, Ann Von Worley
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4920; DOI: 10.1183/13993003.congress-2016.PA4920
  • Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
    Boyang Zheng, Julie Morisset, Sandra Chartrand, Bruno Pierre Dubé
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4874; DOI: 10.1183/13993003.congress-2016.PA4874
  • Pulmonary involvement in children with rheumatic diseases
    Nagehan Emiralioglu, Ezgi Deniz Batu, Emine Sonmez, Gokcen Dilsa Tugcu, Serap Arici, Ebru Yalcin, Deniz Dogru, Ugur Ozcelik, Yelda Bilginer, Mithat Haliloglu, Seza Ozen, Nural Kiper
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4879; DOI: 10.1183/13993003.congress-2016.PA4879
  • Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD)
    Francesco Bonella, Yan Lyu, Dirk Theegarten, Eda Boerner, Thomas E. Wessendorf, Ohshimo Shinichiro, Josune Guzman, Ulrich Costabel, Michael Kreuter
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4877; DOI: 10.1183/13993003.congress-2016.PA4877
  • Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
    Janne Møller, Alan Altraja, Tone Sjåheim, Line Bille Madsen, Finn Rasmussen, Elisabeth Bendstrup
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4876; DOI: 10.1183/13993003.congress-2016.PA4876
  • Constrictive (obliterative) bronchiolitis as presenting manifestation of connective tissue disease
    Antonella Arcadu, Jay Ryu
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4882; DOI: 10.1183/13993003.congress-2016.PA4882
  • Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
    Keita Sakamoto, Shinyu Izumi, Masao Hashimoto, Konomi Kobayashi, Ayako Shiozawa, Eriko Suzuki, Shota Yamamoto, Tomoyuki Suzuki, Satoru Ishi, Eriko Morino, Manabu Suzuki, Jin Takasaki, Go Naka, Hiroyuki Yamashita, Motoyasu Iikura, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4881; DOI: 10.1183/13993003.congress-2016.PA4881
  • Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease?
    Hanna Nurmi, Minna Purokivi, Miia Kärkkäinen, Hannu-Pekka Kettunen, Tuomas Selander, Riitta Kaarteenaho
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4885; DOI: 10.1183/13993003.congress-2016.PA4885
  • Rituximab in severe, progressive interstitial lung disease
    Maria Kokosi, Gregory J. Keir, Tamera J. Corte, Lauren Troy, Peter Saunders, Felix Chua, Toby M. Maher, Elisabetta A. Renzoni, Athol U. Wells
    European Respiratory Journal Sep 2016, 48 (suppl 60) PA4886; DOI: 10.1183/13993003.congress-2016.PA4886

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
  • Acute lung injury and critical care (82)
  • Asthma and allergy (635)
  • CF and non-CF bronchiectasis (272)
  • COPD and smoking (902)
  • Epidemiology, occupational and environmental lung disease (212)
  • Genetics (58)
  • Interstitial and orphan lung disease (485)
  • Lung biology and experimental studies (309)
  • Lung cancer (277)
  • Lung imaging (41)
  • Lung structure and function (303)
  • Mechanisms of lung disease (144)
  • Paediatric pulmonology (392)
  • Pulmonary pharmacology and therapeutics (140)
  • Pulmonary vascular disease (509)
  • Respiratory clinical practice (167)
  • Respiratory infections and tuberculosis (949)
  • Sleep medicine (263)
  • Most Read
  • Twitter
Loading
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • Pulsus paradoxus
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
  • Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society